<DOC>
	<DOC>NCT00109083</DOC>
	<brief_summary>The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.</brief_summary>
	<brief_title>A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Established history of migraines for at least 1 year; Have between 3 and 12 migraine attacks per month, and no more than 15 headache days in total per month; Migraines must have first started before age 50. Most frequent headache type is not migraine; Failed 3 or more studies of effective migrainepreventing medications; Overuse of pain medications to treat migraines; Not willing to stop use of migrainepreventing medications; Significant serious concomitant diseases.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Headaches</keyword>
	<keyword>Migraine headaches</keyword>
	<keyword>Head pain</keyword>
</DOC>